Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
38.55
-0.30 (-0.76%)
Nov 21, 2024, 2:24 PM EST - Market open
Verona Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3,155 | 1,709 | 2,133 | 444 | 405 | 76 | |
| Market Cap Growth | 67.71% | -19.90% | 380.79% | 9.47% | 435.09% | -40.38% | |
| Enterprise Value | 2,965 | 1,472 | 1,907 | 283 | 205 | 27 | |
| Last Close Price | 38.85 | 19.88 | 26.13 | 6.72 | 7.00 | 5.75 | |
| PS Ratio | 415.56 | - | 4657.40 | 11.09 | - | - | |
| PB Ratio | 24.36 | 6.85 | 9.26 | 3.00 | 2.19 | 1.77 | |
| P/TBV Ratio | 17.99 | 6.87 | 9.28 | 3.01 | 2.20 | 1.80 | |
| EV/Sales Ratio | 527.28 | - | 4164.23 | 7.09 | - | - | |
| Debt / Equity Ratio | 0.94 | 0.21 | 0.05 | 0.04 | 0.03 | 0.03 | |
| Asset Turnover | 0.02 | - | 0.00 | 0.20 | - | - | |
| Quick Ratio | 12.47 | 32.53 | 12.46 | 4.91 | 13.82 | 3.94 | |
| Current Ratio | 13.03 | 33.33 | 12.77 | 5.09 | 14.26 | 4.23 | |
| Return on Equity (ROE) | -78.03% | -22.67% | -36.30% | -33.39% | -57.25% | -64.01% | |
| Return on Assets (ROA) | -28.05% | -14.64% | -17.97% | -18.45% | -31.68% | -34.72% | |
| Return on Capital (ROIC) | -35.24% | -15.34% | -20.29% | -20.92% | -35.14% | -42.11% | |
| Earnings Yield | -4.85% | -3.18% | -3.22% | -12.53% | -16.07% | -53.55% | |
| FCF Yield | -3.28% | -2.94% | -2.81% | -7.50% | -11.14% | -56.67% | |
| Buyback Yield / Dilution | -3.55% | -19.86% | -11.81% | -79.97% | -149.64% | -0.21% | |
| Total Shareholder Return | -3.55% | -19.86% | -11.81% | -79.97% | -149.64% | -0.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.